Table 2.
| Contents | Anti-calculative effect of IL-6 | The lithophilic effect of IL-6 |
|---|---|---|
| Model | Mice | Rats |
| Inducing medications | Glyoxylate (GA) | Ethylene glycol(EG)and ammonium chloride(AC) |
| Mode of intervention | Mice were administered 75 mg/kg body weight of glyoxonic acid by intraperitoneal injection for 6 consecutive days. | EG is provided as drinking water for 3 weeks. AC is given by gavage for the first three days of the first and third weeks at 2 mL/animal per day. |
| Signaling pathways | IL-6/JAK/STAT3 activates → inhibits DAO expression → reduces endogenous oxalate synthesis | IL-6 mediates oxidative stress (e.g., 8-OHdG↑) → promotes the inflammatory microenvironment → crystal adhesion |
| Core mechanics | Metabolic regulation: Reduces oxalic acid production | Inflammatory damage: oxidative stress exacerbates tubular epithelial damage |
| Biomarkers | DAO expression ↓, serum/urine oxalate level ↓ | 8-OHdG↑, MDA↑, SOD activity↓ |
| Functional positioning | Inhibition of upstream oxalic acid synthesis | Downstream crystal deposition facilitation |
In the formation of calcium oxalate kidney stones, IL-6 shows a dual regulation of “early protection - late injury”: In the early stage, it induces methylation of the DAO gene through the JAK/STAT3 pathway and inhibits oxalate synthesis; In the late stage, the ROS/NF-κB pathway is activated under the drive of chronic inflammation, and the increased oxidative stress promotes crystal deposition.